Tuttle Capital Management, LLC Amgen Inc Transaction History

Tuttle Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $603,817 - $703,650	-2,721 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $183,057 - $217,988	846 Added 45.12%	2,721 $626,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $439,968 - $489,281	1,875 New	1,875 $477,000
Q4 2019 Jan 13, 2020	SELL	$189.21 - $243.2 $1.99 Million - $2.56 Million	-10,526 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $1.83 Million - $2.2 Million	10,526 New	10,526 $2.2 Million
Q4 2018 Jan 31, 2019	SELL	$178.4 - $208.25 $1.98 Million - $2.31 Million	-11,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $2.06 Million - $2.32 Million	11,100 New	11,100 $2.3 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.